Alembic Pharmaceuticals Limited — Quarter and financial year ended 31st March, 2026
Standalone Audited Financial Results (Rs. in Crores)
| Sr. No | Particulars | Quarter Ended 31.03.2026 (Audited) | Quarter Ended 31.12.2025 (Unaudited) | Quarter Ended 31.03.2025 (Audited) | Year Ended 31.03.2026 (Audited) | Year Ended 31.03.2025 (Audited) |
|---|---|---|---|---|---|---|
| 1 | Revenue from Operations | 1,718.74 | 1,642.24 | 1,570.64 | 6,651.38 | 6,032.63 |
| 2 | Other Income | 25.88 | 10.73 | 13.21 | 55.90 | 47.88 |
| 3 | Total Income | 1,744.62 | 1,652.97 | 1,583.85 | 6,707.28 | 6,080.51 |
| 4 (a) | Expenses – Cost of Materials consumed | 404.24 | 448.73 | 426.20 | 1,747.38 | 1,672.17 |
| 4 (b) | Expenses – Purchase of stock-in-trade | 94.37 | 104.73 | 89.54 | 394.57 | 385.14 |
| 4 (c) | Expenses – Changes in Inventories of finished goods, Stock in trade and WIP | 16.32 | (48.77) | 34.06 | (121.15) | (268.54) |
| 4 (d) | Expenses – Employee benefits expense | 407.03 | 401.36 | 373.27 | 1,612.90 | 1,466.57 |
| 4 (e) | Expenses – Finance Costs | 19.42 | 21.65 | 23.71 | 86.51 | 76.47 |
| 4 (f) | Expenses – Depreciation & Amortization Expense | 82.31 | 79.57 | 68.60 | 311.00 | 277.08 |
| 4 (g) | Expenses – Other Expenses | 522.72 | 464.58 | 476.92 | 1,954.96 | 1,875.90 |
| 4 | Total Expenses | 1,546.40 | 1,471.95 | 1,492.29 | 5,986.17 | 5,484.80 |
| 5 | Profit Before Exceptional Item and Tax | 198.21 | 181.02 | 91.56 | 721.10 | 595.72 |
| 6 | Exceptional Item – Refer Note No. 2, 3 & 4 | (24.76) | (42.23) | – | (66.99) | 12.87 |
| 7 | Profit Before Tax | 173.46 | 138.78 | 91.56 | 654.11 | 608.59 |
| 8 (i) | Tax Expense – Current Tax | 31.84 | 24.31 | 16.73 | 115.14 | 105.98 |
| 8 (ii) | Tax Expense – Deferred Tax | (101.45) | – | – | (101.45) | – |
| 8 (iii) | Tax Expense – Short / (Excess) Tax Provision | – | – | (0.51) | – | (0.51) |
| 9 | Profit for the Period | 243.07 | 114.47 | 75.34 | 640.42 | 503.12 |
| 10 (i) | Other Comprehensive Income – Items that will not be reclassified to profit / (loss) | 0.39 | 2.65 | 1.62 | (4.61) | (1.89) |
| 10 (ii) | Other Comprehensive Income – Income tax relating to items that will not be reclassified to profit / (loss) | 0.06 | (0.46) | 0.21 | 0.93 | 0.82 |
| 11 | Total Comprehensive Income for the period | 243.51 | 116.66 | 77.16 | 636.74 | 502.05 |
| 12 | Earnings per share – Basic & Diluted (in Rs.) | 12.37 | 5.82 | 3.83 | 32.58 | 25.60 |
| 13 | Paid up Equity Share Capital (Face Value of Rs 2/- each) | 39.31 | 39.31 | 39.31 | 39.31 | 39.31 |
| 14 | Other Equity | – | – | – | 5,575.95 | 5,155.43 |
Standalone Disclosures (Regulation 52(4)) (Rs. in Crores where applicable; ratios in times/%)
| Sr. No | Particulars | Quarter Ended 31.03.2026 | Quarter Ended 31.12.2025 | Quarter Ended 31.03.2025 | Year Ended 31.03.2026 | Year Ended 31.03.2025 |
|---|---|---|---|---|---|---|
| a | Debt-Equity Ratio (in times) | 0.20 | 0.23 | 0.22 | 0.20 | 0.22 |
| b | Debt Service Coverage Ratio (in times) | 9.93 | 7.41 | 4.86 | 8.56 | 8.96 |
| c | Interest Service Coverage Ratio (in times) | 9.93 | 7.41 | 4.86 | 8.56 | 8.96 |
| d | Net Worth (Rs. in Crores) | 5,621.34 | 5,374.80 | 5,197.79 | 5,621.34 | 5,197.79 |
| e | Current Ratio (in times) | 1.70 | 1.68 | 1.71 | 1.70 | 1.71 |
| Bad Debts to Accounts Receivable Ratio (%) | – | – | 0.00% | 0.03% | 0.36% | |
| g | Current Liability Ratio (in times) | 0.93 | 0.95 | 0.93 | 0.93 | 0.93 |
| h | Total Debts to Total Assets (in times) | 0.15 | 0.17 | 0.16 | 0.15 | 0.16 |
| i | Debtors Turnover Ratio (in times) | 4.39 | 4.46 | 4.38 | 4.24 | 4.20 |
| j | Inventory Turnover (in times) | 5.81 | 5.56 | 6.37 | 5.63 | 6.12 |
| k | Operating Margin (%) | 17.45% | 17.19% | 11.71% | 16.82% | 15.74% |
| l | Net Profit Margin (%) | 14.14% | 6.97% | 4.80% | 9.63% | 8.34% |
Standalone Statement of Assets and Liabilities (Rs. in Crores)
| Particulars | As at 31st March, 2026 (Audited) | As at 31st March, 2025 (Audited) |
|---|---|---|
| A ASSETS | ||
| 1 Non-current assets | ||
| (a) Property, plant and equipment | 2,828.42 | 2,513.47 |
| (b) Capital work-in-progress | 633.70 | 837.23 |
| (d) Intangible assets under development | 49.70 | – |
| (c) Financial Assets – (i) Investments | 271.40 | 259.56 |
| (c) Financial Assets – (ii) Loan | 141.93 | 71.24 |
| (d) Deferred tax assets (net) | 179.66 | 77.42 |
| (e) Other non-current assets | 15.43 | 31.15 |
| 2 Current assets | ||
| (a) Inventories | 2,048.16 | 1,976.34 |
| (b) Financial Assets – Trade receivables | 1,603.75 | 1,480.67 |
| (b) Financial Assets – Cash and cash equivalents | 22.67 | 14.23 |
| (b) Financial Assets – Bank balances other than cash and cash equivalents | 6.07 | 6.62 |
| (b) Financial Assets – Loans | 12.19 | 12.88 |
| (b) Financial Assets – Others financial assets | 13.40 | 10.47 |
| (c) Current Tax Assets (Net) | 10.68 | 9.21 |
| (d) Other current assets | 284.10 | 255.78 |
| Assets classified as held for sale | 30.00 | – |
| TOTAL – ASSETS | 8,151.25 | 7,556.27 |
| B EQUITY AND LIABILITIES | ||
| 1 Equity – (a) Equity Share capital | 39.31 | 39.31 |
| 1 Equity – (b) Other Equity | 5,575.95 | 5,155.43 |
| 2 Non-current liabilities – (a) Financial liabilities – Lease liabilities | 26.92 | 37.62 |
| 2 Non-current liabilities – (b) Provisions | 152.91 | 124.31 |
| 3 Current liabilities – (a) Financial liabilities – Borrowings | 1,149.49 | 1,142.22 |
| 3 Current liabilities – (a) Financial liabilities – Lease liabilities | 21.67 | 14.09 |
| 3 Current liabilities – (a) Financial liabilities – Trade payables – A) Due to Micro and Small Enterprises | 59.77 | 60.34 |
| 3 Current liabilities – (a) Financial liabilities – Trade payables – B) Due to other than Micro and Small Enterprises | 600.93 | 664.23 |
| 3 Current liabilities – (a) Financial liabilities – Other financial liabilities | 289.19 | 149.33 |
| 3 Current liabilities – (b) Other current liabilities | 70.27 | 66.62 |
| 3 Current liabilities – (c) Provisions | 110.42 | 85.27 |
| 3 Current liabilities – (d) Current Tax Liabilities (Net) | 54.41 | 17.49 |
| TOTAL – EQUITY AND LIABILITIES | 8,151.25 | 7,556.27 |
Standalone Statement of Cash Flows (Rs. in Crores)
| Particulars | For the year ended 31st March, 2026 (Audited) | For the year ended 31st March, 2025 (Audited) |
|---|---|---|
| A CASH FLOWS FROM OPERATING ACTIVITIES: | ||
| Net Profit Before Tax as per Statement of Profit and Loss (After Exceptional item) | 654.11 | 608.59 |
| Adjustments for: Depreciation and amortisation | 311.00 | 277.08 |
| Adjustments for: Interest Expense | 86.51 | 76.47 |
| Adjustments for: Interest Income | (7.29) | (9.09) |
| Adjustments for: Dividend Income / Gain on Sale of Investments | (0.40) | (1.08) |
| Adjustments for: Non Cash Exceptional Item | 18.35 | – |
| Adjustments for: Unrealised foreign exchange (gain) / loss (net) | 16.34 | 24.27 |
| Adjustments for: Fair value (gain)/ loss on financial instruments at fair value through profit or loss | 0.84 | (0.40) |
| Adjustments for: Provision / write off for doubtful trade receivables | 0.93 | 1.05 |
| Adjustments for: Sundry balances written off / written-back (net) | 0.00 | 0.02 |
| Adjustments for: Loss/(Profit) on sale of Asset | 2.17 | (3.26) |
| Operating Profit before change in working capital | 1,082.57 | 973.67 |
| Working capital changes: (Increase) In Inventories | (71.81) | (623.27) |
| Working capital changes: (Increase)/Decrease In Trade Receivables | (84.42) | (165.67) |
| Working capital changes: (Increase) In Other Assets | (28.48) | (39.56) |
| Working capital changes: Increase/(Decrease) In Trade Payables | (68.33) | 106.51 |
| Working capital changes: Increase/(Decrease) In Other Liabilities | 10.96 | (1.87) |
| Working capital changes: Increase/(Decrease) In Provisions | 48.51 | 22.42 |
| Cash generated from operations | 889.00 | 272.23 |
| Direct taxes paid (Net) | (79.54) | (45.67) |
| Net Cash inflow from Operating Activities (A) | 809.46 | 226.57 |
| B CASH FLOWS FROM INVESTING ACTIVITIES: | ||
| Proceeds from Sale of Asset | 2.17 | 9.77 |
| Loan to subsidiary company | (57.34) | (67.00) |
| Interest received | 6.84 | 4.22 |
| Dividend / Gain on Sale of Investments received | 0.40 | 1.08 |
| Purchase of Property, Plant & Equipment and Capital Advance | (431.97) | (563.01) |
| Purchase of Intangible assets under Development | (3.37) | – |
| Investment in Alternative Investment Equity Fund | – | (5.00) |
| Investment in Unquoted Equity / Preference Shares | – | (16.13) |
| Investment in Subsidiary | (0.16) | – |
| Net Cash inflow from Investing Activities (B) | (483.43) | (636.08) |
| C CASH FLOWS FROM FINANCING ACTIVITIES: | ||
| Net Proceeds / (Payments) in short term borrowings | 7.27 | 722.18 |
| Payment of lease liabilities | (23.51) | (24.90) |
| Increase in Restricted Bank Balances other than Cash & Cash Equivalents | (0.02) | (0.03) |
| Dividends paid | (216.22) | (216.22) |
| Interest and other finance costs | (85.12) | (77.42) |
| Net Cash inflow from Financing Activities (C) | (317.59) | 403.61 |
| I Net (Decrease)/Increase in cash and cash equivalents (A+B+C) | 8.44 | (5.90) |
| II. Cash and cash equivalents at the beginning of the Year | 14.23 | 20.13 |
| III. Cash and cash equivalents at the end of the period (I+II) | 22.67 | 14.23 |
| IV. Cash and cash equivalents at the end of the period: Balances with Banks | 22.39 | 13.77 |
| IV. Cash and cash equivalents at the end of the period: Cash on hand | 0.28 | 0.46 |
| Cash and cash equivalents | 22.67 | 14.23 |
Consolidated Audited Financial Results (Rs. in Crores)
| Particulars | Quarter Ended 31.03.2026 (Audited) | Quarter Ended 31.12.2025 (Unaudited) | Quarter Ended 31.03.2025 (Audited) | Year Ended 31.03.2026 (Audited) | Year Ended 31.03.2025 (Audited) |
|---|---|---|---|---|---|
| 1. Revenue from Operations | 1,847.72 | 1,876.31 | 1,769.64 | 7,344.90 | 6,672.08 |
| 2. Other Income | 25.50 | 15.50 | 14.19 | 54.41 | 42.55 |
| 3. Total Income | 1,873.22 | 1,891.81 | 1,783.83 | 7,399.31 | 6,714.63 |
| 4 (a) Expenses – Cost of Materials consumed | 404.24 | 448.73 | 426.20 | 1,747.38 | 1,672.17 |
| 4 (b) Expenses – Purchase of stock-in-trade | 129.79 | 143.11 | 92.64 | 508.88 | 410.96 |
| 4 (c) Expenses – Changes in Inventories of finished goods, Stock in trade and WIP | (1.88) | (62.87) | 11.77 | (271.81) | (289.77) |
| 4 (d) Expenses – Employee benefits expense | 438.91 | 432.71 | 393.59 | 1,731.93 | 1,562.34 |
| 4 (e) Expenses – Finance Costs | 22.56 | 23.31 | 24.52 | 93.63 | 78.77 |
| 4 (f) Expenses – Depreciation & Amortization Expense |